Pachman LM - Search Results

1

MicroRNA-10a Regulation of Proinflammatory Mediators: An Important Component of Untreated Juvenile Dermatomyositis.

Xu D, Huang CC, Kachaochana A, Morgan GA, Bonaldo MF, Soares MB, Costa F, Sarwark J, Sredni ST, Pachman LM. Xu D, et al. Among authors: pachman lm. J Rheumatol. 2016 Jan;43(1):161-8. doi: 10.3899/jrheum.141474. Epub 2015 Dec 1. J Rheumatol. 2016. PMID: 26628598

2

Increased plasma thrombospondin-1 (TSP-1) levels are associated with the TNF alpha-308A allele in children with juvenile dermatomyositis.

Lutz J, Huwiler KG, Fedczyna T, Lechman TS, Crawford S, Kinsella TR, Pachman LM. Lutz J, et al. Among authors: pachman lm. Clin Immunol. 2002 Jun;103(3 Pt 1):260-3. doi: 10.1006/clim.2001.5212. Clin Immunol. 2002. PMID: 12173300

3

Disease activity score for children with juvenile dermatomyositis: reliability and validity evidence.

Bode RK, Klein-Gitelman MS, Miller ML, Lechman TS, Pachman LM. Bode RK, et al. Among authors: pachman lm. Arthritis Rheum. 2003 Feb 15;49(1):7-15. doi: 10.1002/art.10924. Arthritis Rheum. 2003. PMID: 12579588 Free article.

4

Cytokines in juvenile dermatomyositis pathophysiology: potential and challenge.

Uzel G, Pachman LM. Uzel G, et al. Among authors: pachman lm. Curr Opin Rheumatol. 2003 Nov;15(6):691-7. doi: 10.1097/00002281-200311000-00003. Curr Opin Rheumatol. 2003. PMID: 14569197 Review.

5

Skin involvement in juvenile dermatomyositis is associated with loss of end row nailfold capillary loops.

Smith RL, Sundberg J, Shamiyah E, Dyer A, Pachman LM. Smith RL, et al. Among authors: pachman lm. J Rheumatol. 2004 Aug;31(8):1644-9. J Rheumatol. 2004. PMID: 15290747

6

Duration of illness is an important variable for untreated children with juvenile dermatomyositis.

Pachman LM, Abbott K, Sinacore JM, Amoruso L, Dyer A, Lipton R, Ilowite N, Hom C, Cawkwell G, White A, Rivas-Chacon R, Kimura Y, Ray L, Ramsey-Goldman R. Pachman LM, et al. J Pediatr. 2006 Feb;148(2):247-53. doi: 10.1016/j.jpeds.2005.10.032. J Pediatr. 2006. PMID: 16492437

7

Clinical manifestations and pathogenesis of hydroxyapatite crystal deposition in juvenile dermatomyositis.

Pachman LM, Boskey AL. Pachman LM, et al. Curr Rheumatol Rep. 2006 Jun;8(3):236-43. doi: 10.1007/s11926-996-0031-5. Curr Rheumatol Rep. 2006. PMID: 16901083 Review.

8

RANKL:osteoprotegerin ratio and bone mineral density in children with untreated juvenile dermatomyositis.

Rouster-Stevens KA, Langman CB, Price HE, Seshadri R, Shore RM, Abbott K, Pachman LM. Rouster-Stevens KA, et al. Among authors: pachman lm. Arthritis Rheum. 2007 Mar;56(3):977-83. doi: 10.1002/art.22433. Arthritis Rheum. 2007. PMID: 17328075 Free article.

9

Persistent association of nailfold capillaroscopy changes and skin involvement over thirty-six months with duration of untreated disease in patients with juvenile dermatomyositis.

Christen-Zaech S, Seshadri R, Sundberg J, Paller AS, Pachman LM. Christen-Zaech S, et al. Among authors: pachman lm. Arthritis Rheum. 2008 Feb;58(2):571-6. doi: 10.1002/art.23299. Arthritis Rheum. 2008. PMID: 18240225 Free PMC article.

10

The role of aggressive corticosteroid therapy in patients with juvenile dermatomyositis: a propensity score analysis.

Seshadri R, Feldman BM, Ilowite N, Cawkwell G, Pachman LM. Seshadri R, et al. Among authors: pachman lm. Arthritis Rheum. 2008 Jul 15;59(7):989-95. doi: 10.1002/art.23829. Arthritis Rheum. 2008. PMID: 18576304 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

208 results

Search Page

Filters